Literature DB >> 20142445

Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke.

Gregg C Fonarow1, Mathew J Reeves, Xin Zhao, DaiWai M Olson, Eric E Smith, Jeffrey L Saver, Lee H Schwamm.   

Abstract

BACKGROUND: Prior studies have suggested lower use of guideline-recommended therapy and worse poststroke outcomes in older patients. We sought to examine age-related differences in characteristics, performance measures, temporal trends, and early clinical outcomes for acute ischemic stroke in a large contemporary cohort. METHODS AND
RESULTS: The relationships between age and clinical characteristics, performance measures, and in-hospital outcomes were analyzed in 502 036 ischemic stroke admissions from 1256 hospitals in the Get With the Guidelines-Stroke program from 2003 to 2009. Data were analyzed by age groups (<50, 50 to 59, 60 to 69, 70 to 79, 80 to 89, and >/=90 years) and with age as a continuous variable. Seven predefined performance measures and 2 summary measures were analyzed. Mean age of ischemic stroke patients was 71.0+/-14.6 years; 52.5% were women. Older patients were more likely to have a history of atrial fibrillation or hypertension and less likely to be black, Hispanic, or current/recent smokers. Although modest age-related differences in each individual performance measure were identified, there were substantial temporal improvements in performance measures from 2003 to 2009 in each age group, and many age-related treatment gaps were narrowed or eliminated over time. Older patients were less likely to be discharged home (adjusted odds ratio, 0.69; 95% confidence interval, 0.68 to 0.69) and more likely to die in hospital (adjusted odds ratio, 1.27; 95% confidence interval, 1.25 to 1.29) for each 10-year age increase.
CONCLUSIONS: Older patients with ischemic stroke differ in clinical characteristics and experience higher in-hospital mortality than younger patients. Performance measure-based treatment rates improved substantially over time for ischemic stroke patients in all age groups, resulting in smaller age-related treatment gaps.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142445     DOI: 10.1161/CIRCULATIONAHA.109.892497

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  61 in total

Review 1.  Changes in stroke epidemiology, prevention, and treatment.

Authors:  Scott Kinlay
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

2.  Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service Program.

Authors:  Natalia S Rost; Eric E Smith; Muhammad A Pervez; Philip Mello; Paul Dreyer; Lee H Schwamm
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-04-24

3.  Charlson comorbidity index as a predictor of in-hospital death in acute ischemic stroke among very old patients: a single-cohort perspective study.

Authors:  Lorenzo Falsetti; Giovanna Viticchi; Nicola Tarquinio; Mauro Silvestrini; William Capeci; Vania Catozzo; Agnese Fioranelli; Laura Buratti; Francesco Pellegrini
Journal:  Neurol Sci       Date:  2016-05-11       Impact factor: 3.307

Review 4.  Astrocytic response to cerebral ischemia is influenced by sex differences and impaired by aging.

Authors:  Nioka C Chisholm; Farida Sohrabji
Journal:  Neurobiol Dis       Date:  2015-04-02       Impact factor: 5.996

5.  To anticoagulate or not to anticoagulate? That is the question : A Medline-based quantitative approach to share evidence on common clinical problems.

Authors:  Simone Birocchi; Giulia Cernuschi; Gian Marco Podda; Giorgio Costantino
Journal:  Intern Emerg Med       Date:  2012-07-31       Impact factor: 3.397

Review 6.  Ischaemic stroke in young adults: risk factors and long-term consequences.

Authors:  Noortje A M M Maaijwee; Loes C A Rutten-Jacobs; Pauline Schaapsmeerders; Ewoud J van Dijk; Frank-Erik de Leeuw
Journal:  Nat Rev Neurol       Date:  2014-04-29       Impact factor: 42.937

7.  Age-related differences in interferon regulatory factor-4 and -5 signaling in ischemic brains of mice.

Authors:  Shou-Cai Zhao; Chun Wang; Heng Xu; Wen-Qian Wu; Zhao-Hu Chu; Ling-Song Ma; Ying-Dong Zhang; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-09-14       Impact factor: 6.150

8.  Endothelin-1-induced focal cerebral ischemia in the growth hormone/IGF-1 deficient Lewis Dwarf rat.

Authors:  Han Yan; Matthew Mitschelen; Peter Toth; Nicole M Ashpole; Julie A Farley; Erik L Hodges; Junie P Warrington; Song Han; Kar-Ming Fung; Anna Csiszar; Zoltan Ungvari; William E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-08-06       Impact factor: 6.053

9.  TICI and Age: What's the Score?

Authors:  L A Slater; J M Coutinho; J Gralla; R G Nogueira; A Bonafé; A Dávalos; R Jahan; E Levy; B J Baxter; J L Saver; V M Pereira
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-26       Impact factor: 3.825

10.  Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis: Abscess Formation in the Tumor Leading to Bacteremia and Seizure.

Authors:  Maki Kitagawa; Toshimori Koh; Noboru Nakagawa; Yutaka Kondo; Minoru Nishio; Atsushi Oguro; Chohei Sakakura; Masaaki Nanri; Eigo Otsuji
Journal:  Case Rep Gastroenterol       Date:  2010-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.